The Asian Pacific Journal of Cancer Biology (APJCB) is an open access electronic journal, which covers all aspects of cancer research including basic, preclinical, clinical, translational, molecular, epidemiological, prevention, therapy, and rehabilitation. It lays a strong grounding forum for Oncologists, Physician, General Surgeons, Gynecologists, Dermatologists, Gastroenterologists, Pulmonologists, Radiologists, Pathologists, Epidemiologists and Researchers as Cancer research is one of the most cited field. The journal was launched in 2016 as the official publication of the West Asia Organization for Cancer Prevention (WAOCP) and its first volume with 4 articles was published in 2016. All manuscripts published in the Asia Pacific Journal of Cancer Biology, are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the published work, provided the original work and source are appropriately cited.
The Asian pacific Journal of Cancer Biology objective is to be a medium of information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research across Asia and Pacific Region and internationally. It publishes original research articles, systematic and narrative literature reviews, clinical trial protocols, guest editorials, letters to the Editor related to the basic science of cancer. The editor welcomes contributions from a wide spectrum of basic science of cancer especially in the fields of:
The journal adheres to the Uniform Requirements for Manuscripts Submitted to Biomedcal Journals, issued by the International Committee for Medical Journal Editors (ICMJE) and the guidelines of CommiĴ ee on Publication Ethics (COPE).
All articles that are due to publish in the APJCB are subject to rigorous blind peer review (a single blind review in which authors are blinded to reviewers but reviewers can see the name and affiliation of the authors) by field-related researchers and editorial decisions are made by an appropriate team of active-academics in the field, supported by a team of internationally known cancer scientists. Articles are reviewed by at least two independent reviewers. APJCB journal attempts to make a policy of encouraging contribution of authors to expedite reviewing process through their commitment to undertake alternative manuscript reviews. The optional mutual collaboration of journal and authors will contribute to the benefits of our authors and readers as an added incentive to the undertaken reviewing of manuscripts. On the other hand, the journal approves the authors’ suggestion for reviewers to undertake their manuscript in the field. Should any dependency to the work are found in the review process, it will be at journal discretion to replace the reviewer with an independent new one. In line with APJCB policy to develop inter-collaboration among researchers, it will be more prospecting to be chosen if the suggested reviewers are from a different research community from another country. The articles are asked to be reviewed within a two-week period with prompt five-day interval reminders to reviewers during this step. Reviewers must declare conflict of interest.
APJCB is adopted transparent and thorough instructions for best working practices in scientific publishing, working in conjunction with our academic partners. Such policies will benefit our authors, editors, and readers as we strive for a trustworthy, transparent and efficient publishing process. Responsibility for the journal and its policies lies with the Editor-in-Chief in conjunction with the Publisher; any concerns either regarding specific papers or general policies should be directed to the Editor-in-Cheif.
Articles published in Asian Pacific Journal of Cancer Biology are 'open access'. A universally accepted definition of the term is provided in the Bethesda Statement on Open Access Publishing in 2003:
The article is universally and freely accessible via the Internet, in an easily readable format and deposited immediately upon publication, without embargo, in a PDF format in Journal's site
The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.
Articles in Asian Pacific Journal of Cancer Biology are published under the Creative Commons Attribution License (CC-BY) to ensure implementation of open access as defined.
The Asian Pacific Journal of Cancer Biology's Archive is preserved in PORTICO's repository system. The agreement was signed last year and the APJCB was added to the agreement in May 2017.
APJCB is very sensitive to research misconduct and uses all means available to prevent publishing miscounted research. Though there is no a standard definition of research misconduct, the Council of Science Editors defines research misconduct broadly in three categories of action and conducts:
APJCB uses this definition of the misconduct in its dealing with the issue and follows strictly the COPE follow chart in dealing with research misconduct. In addition, For each component of the research misconduct, APJCB has many assurance policies as follows
APJCB does not publish manuscripts that do not declare a statement about the protection of human subject and acquisition of informed consent when the subject of research is human. Normally, the journal requires that a statement is declared that research has been reviewed by an institutional review board (IRB) either in the material method section of the manuscript or in the acknowledgment section of the manuscript. APJCB encourage authors to report the registry number of the IRB in countries that a central registrar of the IRB exists as it is the case in Islamic Republic Iran.
Falsification and Fabrication of data:
Fabrication is defined as making up of data without actually collecting or synthesizing scientific data. Falsification is defined as the manipulation of research material in order to reach a favorable result. Fabrication and falsification could happen at any stage of research (in the field) up to the publication of manuscript where a misuse of citation can happen (referencing to a citation when the citation does not support the argument). APJCB tries to identify any kind of fabrication or falsification in all level of manuscript processing, from initial screening to comprehensive evaluation of a revised manuscript and even after a manuscript has been published. Report of any fabrication and falsification is an ethical duty of our authors, co-authors, reviewers, editors, and readers. In any event of falsification or fabrication, APJCB keeps its right to retract or withdraw the fabricated or falsified article. APJCB strictly follows the COPE follow chart in dealing with fabrication and falsification.
Plagiarism is defined as the appropriation of another person's ideas, processes, results, or words without giving appropriate credit. Another category of plagiarism is self-plagiarism when author published his own idea, data, and text in different journals when no need of such duplication exists. APJCB uses all means to detect plagiarism. As a matter of quality assurance, a similarity of more than 30 percent in the text of a manuscript will be returned to the author to remove the similarities and reduce the chance of plagiarism. APJCB strictly follows the COPE follow chart in dealing with plagiarised articles.
APJCB considers an author as a person who has substantially contributed in all stages of a research that the manuscript reports its result. In other hands, all authors who are listed in a manuscript have contributed to the research and the manuscript submitted to the journal. There are many different definitions of authorship among different bodies that oversee authorship rights and responsibilities. The COPE define the authorship as “The term authorship can refer to the creator or originator of an idea (eg, the author of the theory of relativity) or the individual or individuals who develop and bring to fruition the product that disseminates intellectual or creative works (eg, the author of a poem or a scholarly article).” International Committee of Medical Journal Editors (ICMJE) bases the authorship on the following four criteria:
APJCB policies in maintaining its high standard of ethics have many provisions that help editorial to establish the authorship requirement that was defined by COPE or ICMJE. For this, APJCB uses its editorial management system to validate the authorship of a manuscript submitted. APJCB’s initial engagement with authors is through its “Editorial Management System”. The system functionally deals with the corresponding author but informs other authors any changes or major steps that are taken in the process of submission, review, revision, editing and final steps of publication. The only means of communication with authors are by email. All listed authors are required to verify their contribution to a submitted manuscript by receiving an email that informs them of the submission and the nature of authorship of the manuscript (author list with the order that is registered in the EMSS). The email clearly validates the contribution of listed authors in the manuscript. In a case that an author disputes the submitted manuscript or his contribution, the journal returns the manuscript to the corresponding author and ask to resubmit when the dispute is resolved. Any authorship dispute, after the initial step, is managed as the COPE recommends. Authors that may need information on authorship right and responsibility and the way handle disputes are referred to the COPE publication on how to handle authorship dispute at (https://publicationethics.org/files/2003pdf12_0.pdf) or to Defining the Role of Authors and Contributors in ICMJE ‘s web site at (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html). We expect that all authors listed in a manuscript will receive the journal’s email and read and the content of the email that is provided for the purpose of authorship validation.
APJCB promote the ethical aspect of research on animals. All research involving animal (no matter large animals or small), must provide evidence of an ethical review board. The evidence could be a statement indicating that the research has been approved by an independent ethical committee placed either in material and method section of the manuscript or as an acknowledgment at the end of the manuscript.
In addition, manuscript submitted to APJCB that involves animals must meet the minimum standard described in ARRIVE guidelines. The guideline consists of information that scientific publication reporting an animal experimentation should report. APJCB encourages its author to read through the guideline and try to provide the minimum information that the guideline recommends, especially details of animal welfare, including information about housing, feeding, and steps taken to minimize suffering, including the use of anesthesia and method of sacrifice.
Asian Pacific Journal of Cancer Biology does not charge any article processing charges (APCs). The publishing cost of APJCB is funded and supported by West Asia Organization for Cancer Prevention (WAOCP).
Asian Pacific Journal of Cancer Biology (APJCB ) does not charge any Submission Charges.